Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000271 · ClinicalTrials.gov registry record · Phase 2
New Approaches to Cocaine Abuse Medications (A) - 6
A Phase 2 study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 111
- Enrollment target
NCT00000271: Completed Phase 2 study, sponsored by New York State Psychiatric Institute.
NCT00000271 is a Phase 2 study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 111 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (17% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000271, a Phase 2 study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 111 participants
- Enrollment target
Study Summary
The purpose of this study is to measure the effect of desipramine in cocaine abusers selected for major depression or dysthymia.
Primary Outcome
Clinical Global Impression Scale, self-reported cocaine use and craving, urine toxicology.
Interventions
- DRUG Placebo
- DRUG Desipramine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 1995-01 |
| Est. Completion | 2002-10 |
| Phase | Phase 2 |
What the finished NCT00000271 record still lists
NCT00000271 is an interventional study that assigns participants to a tested intervention. The registered 111 participants enrollment target is mid-sized for trials with a published cap, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (17% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00000271 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000271 about?
NCT00000271 is a clinical study titled "New Approaches to Cocaine Abuse Medications (A) - 6". The purpose of this study is to measure the effect of desipramine in cocaine abusers selected for major depression or dysthymia.
What is the current status of trial NCT00000271?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 111 participants. The study started on 1995-01. Estimated completion is 2002-10.
What interventions are being tested in trial NCT00000271?
The interventions under investigation include: Placebo (DRUG), Desipramine (DRUG).
Who is sponsoring clinical trial NCT00000271?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00000271's enrollment target sits among peer trials
111 632nd of 2000 higher than 1,369 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03875716 · 111 participants · NA
Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma
- NCT04693468 · 111 participants · Phase 1
Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
- NCT05263050 · 111 participants · Phase 2
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
- NCT05600842 · 111 participants
De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia